Pitolisant

Pitolisant
Names

IUPAC name 1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine
Other names BF2.649
Identifiers
CAS Number	903576-44-3^N
3D model (Jmol)	Interactive image
ChemSpider	8123714^Y
KEGG	D10749^N
PubChem CID	9948102
InChI InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2^Y Key: NNACHAUCXXVJSP-UHFFFAOYSA-N^Y InChI=1/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2 Key: NNACHAUCXXVJSP-UHFFFAOYAL
SMILES Clc1ccc(cc1)CCCOCCCN2CCCCC2
Properties
Chemical formula	C₁₇H₂₆ClNO
Molar mass	295.846 g/mol
Pharmacology
ATC code	N07XX11 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N (what is ^YN ?)
Infobox references

Pitolisant (INN) or tiprolisant (USAN) is a histamine receptor inverse agonist/antagonist selective for the H₃ subtype. It has stimulant and nootropic effects in animal studies, and may have several medical applications, having been researched for the treatment of narcolepsy, for which it has been granted orphan drug status in the EU and US. It is currently in clinical trials for schizophrenia and Parkinson's disease.

Pitolisant was developed by Jean-Charles Schwartz, Walter Schunack and colleagues after the former discovered H₃ receptors. Pitolisant was the first clinically used H₃ receptor inverse agonist.

...
Wikipedia